RobertWSimmsMDProfessor of Medicine

Rheumatology • Lebanon, NH

Rheumatoid Arthritis & Related, Scleroderma & Related

Professor of Medicine, Boston University

Join to view full profile

Dr. Simms is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Simms' full profile

Already have an account?

Office
1 Medical Center Dr
Lebanon, NH 03756
Phone+1 603-650-8622

Education & Training

Boston University Medical CenterFellowship, Rheumatology, 1985 - 1987
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1980 - 1981
University of Rochester School of Medicine and DentistryClass of 1980

Certifications & Licensure

NY State Medical License 1982 - Present
NH State Medical License 2020 - 2026
VT State Medical License 2022 - 2026
MA State Medical License 1982 - 2023
ME State Medical License 2020 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2006-2014
Boston Magazine Castle Connolly, 2008-2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
Completed
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
Completed
Phase 2
Scleroderma Treatment With Autologous Transplant (STAT) Study Start of enrollment: 2011 Sep 15
Active, not recruiting
Phase 2
Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) Start of enrollment: 2013 Oct 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Autologous non-myeloablative hematopoietic stem cell transplantation for diffuse cutaneous systemic sclerosis: identifying disease risk factors for toxicity and long-t...
George E Georges, Dinesh Khanna, Mark H Wener, Matthew G Mei, Maureen D Mayes
Arthritis & Rheumatology. 2024-12-03
8 citations
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
Robert Spiera, Masataka Kuwana, Dinesh Khanna, Laura Hummers, Tracy M Frech
Arthritis & Rheumatology. 2023-09-01
2 citations
Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.
Ankoor Shah, Jan Storek, Rob Woolson, Ashley Pinckney, Lynnette Keyes-Elstein
Rheumatology. 2022-10-06

Journal Articles

Serum Biomarker for Diagnostic Evaluation of Pulmonary Arterial Hypertension in Systemic Sclerosis
Harrison W Farber, Kari Roberts, Nicholas Hill, Robyn Domsic, Robert W Simms, BioMed Central

Grant Support

Core B Clinical CoreNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
High-Dose Immunosuppressive Therapy Using Total Body IrradiationNational Center For Research Resources2007
Infusion Of Recombinant Human Relaxin In Patients W/ SclerodermaNational Center For Research Resources1999–2000
Muscle Metabolism And Muscle Fatigue In Fibromyalgia SyndromeNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1990–1991